Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Teladoc Health
TDOC
Teladoc Health
Accelerated Digitalization And Aging Trends Will Redefine Virtual Care
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 20 Analysts
Published
05 Aug 25
Updated
09 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
US$12.00
42.0% undervalued
intrinsic discount
09 Aug
US$6.96
Loading
1Y
-2.7%
7D
0.3%
Author's Valuation
US$12.0
42.0% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
US$12.0
42.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-10b
3b
2014
2017
2020
2023
2025
2026
2028
Revenue US$2.7b
Earnings US$13.3m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
1.91%
Healthtech revenue growth rate
4.80%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
9.89%
Calculation
US$13.27m
Earnings '28
x
232.70x
PE Ratio '28
=
US$3.09b
Market Cap '28
US$3.09b
Market Cap '28
/
194.18m
No. shares '28
=
US$15.90
Share Price '28
US$15.90
Share Price '28
Discounted to 2025 @ 9.87% p.a.
=
US$11.99
Fair Value '25